Timely Opioid Administration Cuts Hospitalizations for Pediatric Sickle Cell Crises
.jpeg?width=1200)
WEDNESDAY, Sept. 10, 2025 -- Providing timely pain relief may reduce chances of hospitalization for children presenting to the emergency department with a sickle cell crisis, according to a study published online Sept. 2 in JAMA Pediatrics.
Ibrahim Gwarzo, Dr.P.H., M.B.B.S., from Nemours Children’s Health in Wilmington, Delaware, and colleagues examined whether timely administration of opioids (within 60 minutes) in the emergency department is associated with hospitalization for sickle cell disease (SCD) pain. The analysis included 2,538 children (younger than 19 years) seen at 12 children’s hospitals with comprehensive SCD centers (9,233 emergency visits from 2019 through 2021).
The researchers found that first-dose timeliness of opioid administration evaluated alone was associated with decreased hospitalizations (odds ratio [OR], 0.84). For the 7,853 visits (85.1 percent) with two or more opioid doses, first-opioid timeliness was associated with reduced odds of hospitalization, even when the second dose was outside 30 minutes (OR, 0.85) or 45 minutes (OR, 0.84). The lowest odds of hospitalization were seen for first-dose timeliness combined with a second dose within 30-minute (OR, 0.62), 45-minute (OR, 0.70), and 60-minute (OR, 0.78) intervals.
"We demonstrated in our research that ensuring pain relief and providing comfort to patients prevents complications that could arise from prolonged pain and stress, and reduces the likelihood of hospitalization," Gwarzo said in a statement.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Less Than Half of Youths With Sickle Cell Received Dental Services in 2022
FRIDAY, Sept. 5, 2025 -- Only 42 percent of youths with sickle cell disease (SCD) received dental services in 2022, according to a research letter published online Sept. 3 in JAMA...
Discontinuation of Medical Cannabis Common in Musculoskeletal Pain
TUESDAY, Aug. 26, 2025 -- A number of patients with musculoskeletal pain discontinue medical cannabis (MC) within one year, with many discontinuing within the first three months...
AAP Offers Guidance for Tapering of Opioids to Prevent Withdrawal in Children
TUESDAY, Aug. 19, 2025 -- A plan for tapering opioids should be developed to minimize withdrawal symptoms in children receiving opioids for five or more days, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.